Business Context and Reporting Period
SeaStar Medical Holding Corp (ICU) filed a Form 8-K on December 13, 2023, regarding a notice of potential delisting from The Nasdaq Capital Market. The company is an emerging growth company incorporated in Delaware.
Key Financial Metrics
The filing does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The only financial metric disclosed is the market value of the company's common stock, which was less than $35.0 million for 30 consecutive business days preceding the deficiency notices.
Material Changes
On December 12, 2023, the company received a formal Delisting Notice from Nasdaq stating it had failed to regain compliance with the Market Value Rule (Nasdaq Listing Rule 5550(b)(2)). This follows previous deficiency letters issued in June 2023 regarding the same metric.
Outlook, Risks, and Management Commentary
- Management Action: The company intends to timely request a hearing before a Nasdaq Hearing Panel to contest the delisting.
- Immediate Impact: The hearing request will stay any suspension or delisting action pending the hearing outcome.
- Trading Status: Subject to the timely submission of the hearing request, the company's common stock will continue to trade on The Nasdaq Capital Market under the symbol "ICU."
- Risk: Failure to regain compliance or win the hearing could result in the delisting of the company's securities.
Investor Verification Checklist
- Confirm the current market value of the company's common stock to assess compliance with the $35.0 million threshold.
- Verify the status of the hearing request with the Nasdaq Hearing Panel.
- Monitor subsequent filings for the hearing outcome and any potential transfer of listing to another exchange.
- Review the company's capital structure and recent stock price volatility to understand the root cause of the market value decline.